Loading the section
Closing prices for 09 October 2026
Next earnings report: 03 November 2026 · Earnings calendar
The series is stated in the current share scale after splits; dividends are not included in the price
PTC Therapeutics, Inc. trades on Nasdaq under the ticker PTCT. The company belongs to the Health care sector. The trading history on this page starts on 22 August 2016.
Over the past 52 weeks PTCT has traded between 61.23 $ and 90.87 $. As of 09 October 2026 the price stood 11.71 % of the way from the 52-week low to the high.
Over one year PTCT shares rose 0.34 %; over six months they fell 5.81 %. Volatility over 90 days is 39.40 %. Dividends are not included: this is price change only, as of 09 October 2026.
The company reported a loss over the last four quarters, so a price-to-earnings ratio is not calculated. Price to sales is 6.2, above the sector median of 3.9. Calculated from reports for the period ending 31 March 2026.
| Date | Open | High | Low | Close | Volume, shares |
|---|---|---|---|---|---|
| 09 October 2026 | 62.52 | 64.73 | 62.20 | 64.70 | 1M |
| 08 October 2026 | 62.66 | 62.86 | 61.65 | 62.56 | 1M |
| 07 October 2026 | 63.19 | 64.04 | 62.84 | 63.23 | 1M |
| 06 October 2026 | 64.53 | 65.27 |
Based on the last 12 months of reports, through 31 March 2026
The sector median covers every company in the sector on the US market, loss-making ones included.
PTC Therapeutics, Inc. (PTCT) is a public company in the healthcare sector. Its common stock trade on NASDAQ.
Over the trailing twelve months as reported to 2025-12-31, revenue was 1.7bn $, net income was 682.6m $. Incorporated in US.
This summary is compiled automatically from SEC filings and exchange data.
Address:500 WARREN CORPORATE CENTER DRIVE, WARREN, NJ, 07059, US
PTC Therapeutics, Inc. reported revenue of 827M $ and a net loss of 187M $ over the last four quarters. Net margin is −22.58 %. Revenue changed by −53.34 % year over year. Earnings per share are −2.29 $. Market capitalisation is 5.2B $.
| 1.2B |
| PFEPfizer, Inc. | 28.18 | +1.28 % | 929M |
| ABTAbbott Laboratories | 99.60 | +1.13 % | 921M |
| BMYBristol-Myers Squibb Company | 59.12 | −0.77 % | 714M |
| REGNRegeneron Pharmaceuticals, Inc. | 746.54 | +0.94 % | 555M |
| 62.92 |
| 63.70 |
| 1M |
| 05 October 2026 | 63.42 | 64.47 | 62.60 | 63.65 | 1M |
| 02 October 2026 | 64.81 | 65.40 | 62.80 | 63.46 | 895,600 |
| 01 October 2026 | 64.70 | 65.57 | 63.40 | 64.13 | 1M |
| 30 September 2026 | 65.16 | 65.50 | 64.15 | 64.78 | 1M |
| 29 September 2026 | 65.51 | 65.97 | 64.27 | 64.96 | 900,400 |
| 28 September 2026 | 62.35 | 66.26 | 62.30 | 65.95 | 2M |
| 25 September 2026 | 62.65 | 63.44 | 61.66 | 62.67 | 1M |
| 24 September 2026 | 62.23 | 62.76 | 61.23 | 62.28 | 2M |
| 23 September 2026 | 65.80 | 66.15 | 62.24 | 62.34 | 1M |
| 22 September 2026 | 66.24 | 66.58 | 65.36 | 65.96 | 1M |
| 21 September 2026 | 65.93 | 66.21 | 64.99 | 65.26 | 1M |
| 18 September 2026 | 68.00 | 68.01 | 65.18 | 65.37 | 4M |
| 17 September 2026 | 68.84 | 68.84 | 67.22 | 68.00 | 1M |
| 16 September 2026 | 65.99 | 67.90 | 65.80 | 67.59 | 1M |
| 15 September 2026 | 66.51 | 66.54 | 65.06 | 65.65 | 1M |
| 14 September 2026 | 67.09 | 67.99 | 65.91 | 66.48 | 1M |